Multi-drug Resistant Hiv-1 Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-07-11
Clinical Trial Update: A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection [Phase 2]
The Phase 2 trial of UB-421 in combination with optimized background antiretroviral therapy for multi-drug resistant HIV-1 infection has bee…